These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38897622)

  • 1. Identifying the impact of non-pharmaceutical interventions on RSV transmission in a single-centre observational study.
    Betts TA; Darby AE; Hussain F; Edwards M
    BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38897622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023.
    Blatt AZ; Suh M; Walter EB; Wood CT; Espinosa C; Enriquez-Bruce ME; Domachowske J; Daniels D; Budhecha S; Elliott A; Wolf Z; Waddell EB; Movva N; Reichert H; Fryzek JP; Nelson CB
    Influenza Other Respir Viruses; 2024 May; 18(5):e13298. PubMed ID: 38751165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study.
    Presti S; Manti S; Gammeri C; Parisi GF; Papale M; Leonardi S
    Pediatr Pulmonol; 2024 May; 59(5):1298-1304. PubMed ID: 38353390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.
    Bardsley M; Morbey RA; Hughes HE; Beck CR; Watson CH; Zhao H; Ellis J; Smith GE; Elliot AJ
    Lancet Infect Dis; 2023 Jan; 23(1):56-66. PubMed ID: 36063828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.
    Rodríguez-Fernández R; González-Martínez F; Perez-Moreno J; González-Sánchez MI; de la Mata Navazo S; Toledo Del Castillo B; Saavedra Lozano J; Voltas Espinosa L; Manso Perez S; Miñarro Berlanga M; Mejias A; Ramilo O
    Am J Perinatol; 2024 Mar; 41(4):515-521. PubMed ID: 36543242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
    Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
    Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia.
    Foley DA; Phuong LK; Peplinski J; Lim SM; Lee WH; Farhat A; Minney-Smith CA; Martin AC; Mace AO; Sikazwe CT; Le H; Levy A; Hoeppner T; Borland ML; Hazelton B; Moore HC; Blyth C; Yeoh DK; Bowen AC
    Arch Dis Child; 2022 Mar; 107(3):e7. PubMed ID: 34433552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How has the SARS-CoV-2 pandemic changed the epidemiology and management of acute bronchiolitis?
    Brisca G; Mariani M; Buratti S; Ferretti M; Pirlo D; Buffoni I; Mallamaci M; Salvati P; Tagliarini G; Piccotti E; Sacco O; Castagnola E; Moscatelli A
    Pediatr Pulmonol; 2023 Apr; 58(4):1169-1177. PubMed ID: 36636959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.
    Lewis L; Sinha I; Losty PD
    Pediatr Pulmonol; 2022 Jan; 57(1):239-244. PubMed ID: 34617409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).
    Torres-Fernandez D; Casellas A; Mellado MJ; Calvo C; Bassat Q
    J Clin Virol; 2021 Dec; 145():105027. PubMed ID: 34781241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Bronchiolitis Epidemic in French Primary Care Setting Driven by Respiratory Syncytial Virus: Preliminary Data from the Oursyn Study, March 2021.
    Rybak A; Levy C; Jung C; Béchet S; Batard C; Hassid F; Zouari M; Cahn-Sellem F; Bangert M; Cohen R
    Pediatr Infect Dis J; 2021 Dec; 40(12):e511-e514. PubMed ID: 34260480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023.
    Blatt AZ; Suh M; Walter EB; Wood CT; Espinosa C; Enriquez-Bruce ME; Domachowske J; Daniels D; Budhecha S; Elliott A; Wolf Z; Waddell EB; Movva N; Reichert H; Fryzek JP; Nelson CB
    Ann Epidemiol; 2024 Jun; 94():72-80. PubMed ID: 38685519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic.
    Bermúdez Barrezueta L; Matías Del Pozo V; López-Casillas P; Brezmes Raposo M; Gutiérrez Zamorano M; Pino Vázquez MA
    Infection; 2022 Aug; 50(4):1001-1005. PubMed ID: 35316529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus-related bronchiolitis in Puerto Rico.
    Molinari Such M; García I; García L; Puig G; Pedraza L; Marín J; Valcárcel M
    P R Health Sci J; 2005 Jun; 24(2):137-40. PubMed ID: 16116931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
    Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
    Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic.
    Guitart C; Bobillo-Perez S; Alejandre C; Armero G; Launes C; Cambra FJ; Balaguer M; Jordan I;
    BMC Infect Dis; 2022 Jan; 22(1):84. PubMed ID: 35073855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
    Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
    Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
    Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.